Joel D. Meyers
#138,764
Most Influential Person Now
Joel D. Meyers's AcademicInfluence.com Rankings
Joel D. Meyersphilosophy Degrees
Philosophy
#7138
World Rank
#10305
Historical Rank
Logic
#4213
World Rank
#5475
Historical Rank
Joel D. Meyersbiology Degrees
Biology
#9693
World Rank
#12926
Historical Rank
Virology
#224
World Rank
#231
Historical Rank
Immunology
#582
World Rank
#601
Historical Rank
Download Badge
Philosophy Biology
Joel D. Meyers's Degrees
- PhD Immunology Stanford University
- Doctorate Medicine Stanford University
Why Is Joel D. Meyers Influential?
(Suggest an Edit or Addition)Joel D. Meyers's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Risk factors for cytomegalovirus infection after human marrow transplantation. (1986) (807)
- Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. (1995) (798)
- Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. (1991) (678)
- Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant (1993) (653)
- Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. (1991) (573)
- Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. (1988) (523)
- Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. (1982) (510)
- Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. (1986) (501)
- Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. (1988) (438)
- Adenovirus infections in patients undergoing bone-marrow transplantation. (1985) (405)
- Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever—Reply (1991) (391)
- Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. (1990) (378)
- From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. (1990) (365)
- Acyclovir halts progression of herpes zoster in immunocompromised patients. (1983) (357)
- Infection with varicella-zoster virus after marrow transplantation. (1985) (355)
- An outbreak of respiratory syncytial virus in a bone marrow transplant center. (1992) (352)
- Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia. (1985) (336)
- Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. (1982) (304)
- Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. (1993) (302)
- Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine. (1986) (289)
- Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. (1982) (289)
- Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. (1990) (277)
- Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. (1983) (262)
- Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. (1992) (242)
- Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. (1982) (237)
- Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. (1984) (234)
- Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. (2006) (226)
- Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. (1991) (225)
- Protective environment for marrow transplant recipients: a prospective study. (1978) (208)
- Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. (1991) (201)
- Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. (1980) (201)
- Infection in bone marrow transplant recipients. (1986) (198)
- Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. (1994) (194)
- The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation. (1982) (182)
- Treatment of cytomegalovirus pneumonia with high-dose acyclovir. (1982) (177)
- Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. (1983) (172)
- Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. (1988) (169)
- Congenital varicella in term infants: risk reconsidered. (1974) (162)
- Cytomegalovirus infection in sex partners: evidence for sexual transmission. (1985) (158)
- Esophageal infections in immunosuppressed patients after marrow transplantation. (1985) (156)
- VARICELLA‐ZOSTER VIRUS INFECTION AFTER MARROW TRANSPLANTATION FOR APLASTIC ANEMIA OR LEUKEMIA (1980) (151)
- Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. (1991) (150)
- Diagnosis of cytomegaloviral pneumonia by in situ hybridization. (1984) (147)
- Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. (1980) (135)
- Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia (1982) (131)
- Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation. (1983) (124)
- Fungal infections in bone marrow transplant patients. (1990) (121)
- Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment. (1990) (119)
- Infection due to Corynebacterium species in marrow transplant patients. (1979) (117)
- Respiratory virus infection in immunocompromised patients. (1989) (115)
- Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. (1990) (113)
- Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients. (1985) (108)
- Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. (1993) (107)
- Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins. (1982) (107)
- Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. (1987) (106)
- A PROSPECTIVE STUDY OF UNEXPLAINED NAUSEA AND VOMITING AFTER MARROW TRANSPLANTATION (1986) (103)
- Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. (1992) (101)
- Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. (1991) (100)
- Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. (1980) (99)
- Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation. (1990) (97)
- Infection Complicating Bone Marrow Transplantation (1991) (97)
- Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. (1980) (93)
- Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. (1982) (91)
- Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. (1986) (89)
- Giardia lamblia infection in homosexual men. (1977) (87)
- Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. (1987) (87)
- Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. (1984) (83)
- Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission. (1985) (78)
- Cryptosporidiosis after marrow transplantation: person-to-person transmission and treatment with spiramycin. (1984) (74)
- Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids. (1986) (73)
- Use of bronchoalveolar lavage to diagnose acute diffuse pneumonia in the immunocompromised host. (1986) (72)
- Treatment of cytomegaloviral pneumonia with high-dose acyclovir and human leukocyte interferon. (1983) (71)
- The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. (1979) (70)
- Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection. (1990) (70)
- Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen. (1991) (69)
- MYCOBACTERIAL INFECTIONS IN MARROW TRANSPLANT PATIENTS (1983) (68)
- Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody. (1985) (65)
- Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods. (1994) (64)
- Hepatosplenic candidiasis--a contraindication to marrow transplantation? (1994) (62)
- Cytomegalovirus‐seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks (1987) (62)
- Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature (1986) (59)
- Second marrow infusion for poor graft function after allogeneic marrow transplantation. (1986) (58)
- Comparative Trial of Ketoconazole and Nystatin for Prevention of Fungal Infection in Neutropenic Patients Treated in a Protective Environment (1985) (57)
- Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment. (1984) (57)
- Parenterally transmitted non-A, non-B hepatitis: an epidemic reassessed. (1977) (57)
- Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses. (1987) (57)
- Toxoplasma gondii reactivation identified by detection of parasitemia in tissue culture. (1985) (57)
- Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. (1987) (57)
- Efficacy of cytomegalovirus immunoglobulin in marrow transplant recipients with cytomegalovirus pneumonia. (1987) (57)
- Cytomegalovirus infection in women attending a sexually transmitted disease clinic. (1990) (56)
- Prediction by surveillance cultures of bacteremia among neutropenic patients treated in a protective environment. (1983) (55)
- Acyclovir treatment of varicella-zoster virus infection in the compromised host. (1984) (55)
- Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. (1995) (55)
- Hickman catheter complications in marrow transplant recipients. (1986) (54)
- The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients. (1987) (54)
- Early and late interstitial pneumonia following human bone marrow transplantation. (1986) (53)
- SEQUENTIAL INTRAVENOUS AND TWICE‐DAILY ORAL ACYCLOVIR FOR EXTENDED PROPIIZLAXIS OF HEAPFA SIMPLEX VIRUS INFECTION IN MARROW TRANSPIANT PATIENTS (1987) (50)
- Rapid diagnosis of invasive cytomegalovirus infection by examination of tissue specimens in centrifugation culture. (1987) (47)
- Erratum: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever (J. Infec. Dis. 1990; 161:381-396) (1990) (45)
- BWB759U, AN ANALOGUE OF ACYCLOVIR, INHIBITS HUMAN CYTOMEGALOVIRUS IN VITRO (1984) (45)
- Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: Effects of prophylactic measures (1983) (43)
- Epstein‐Barr virus‐related serology in marrow transplant recipients (1980) (41)
- Prevalence and incidence of herpesvirus infections among homosexually active men. (1984) (41)
- Prevention and treatment of cytomegalovirus infection. (1991) (40)
- Prevention of cytomegalovirus infection after marrow transplantation. (1989) (40)
- Use of murine monoclonal antibodies for laboratory diagnosis of varicella-zoster virus infection (1988) (39)
- Parenterally transmitted hepatitis A associated with platelet transfusions. Epidemiologic study of an outbreak in a marrow transplantation center. (1974) (38)
- Endothelial cell damage and tubuloreticular structures in interstitial lung disease associated with collagen vascular disease and viral pneumonia. (2015) (36)
- Rapid cytologic diagnosis of cytomegalovirus interstitial pneumonia on touch imprints from open-lung biopsy. (1982) (34)
- From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS. (1991) (34)
- Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro (1980) (31)
- Nosocomial varicella. Part I: outbreak in oncology patients at a children's hospital. (1979) (31)
- Management of cytomegalovirus infection. (1988) (29)
- Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. (1985) (29)
- A review of five years' experience with rubella vaccine in the United States. (1975) (29)
- Effect of trimethoprim-sulfamethoxazole on hematological recovery after total body irradiation and autologous marrow infusion in dogs. (1979) (28)
- Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment. (1986) (28)
- Diagnosis of cytomegalovirus pneumonia by the polymerase chain reaction with archived frozen lung tissue and bronchoalveolar lavage fluid. (1993) (27)
- The use of acyclovir for cytomegalovirus infections in the immunocompromised host. (1983) (27)
- Cytomegalovirus infection of the tongue following marrow transplantation. (1994) (27)
- Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine. (1988) (26)
- Recombinant leukocyte A interferon for the treatment of serious viral infections after marrow transplant: a phase I study. (1983) (26)
- Intravenous lymphoblastoid interferon and acyclovir for treatment of cytomegaloviral pneumonia. (1984) (25)
- Evaluation of a direct fluorescein-conjugated monoclonal antibody for detection of cytomegalovirus in centrifugation culture (1987) (25)
- Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation. (1990) (25)
- Cytomegalovirus infection after marrow transplantation for aplastic anemia. (1990) (25)
- Detection of cytomegalovirus from clinical specimens in centrifugation culture by in situ DNA hybridization and monoclonal antibody staining (1989) (25)
- Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation. (1985) (23)
- The effects of infection prevention regimens on early infectious complications in marrow transplant patients: A four arm randomized study (1988) (23)
- Prophylaxis of cytomegalovirus infection. (1990) (22)
- Intracardiac infections due to coagulase‐negative staphylococcus associated with hickman catheters (1986) (22)
- Direct detection of cytomegalovirus from bronchoalveolar lavage samples by using a rapid in situ DNA hybridization assay (1989) (22)
- Ganciclovir treatment of cytomegalovirus infection of the gastrointestinal tract after marrow transplantation. (1988) (22)
- Prevention of Nosocomial Infections in Marrow Transplant Patients: A Prospective Randomized Comparison of Systemic Antibiotics Versus Granulocyte Transfusions (1986) (21)
- Cytomegalovirus Infection after Organ Allografting (1985) (21)
- CHLAMYDIA TRACHOMATIS INFECTION AS A CAUSE OF PNEUMONIA AFTER HUMAN MARROW TRANSPLANTATION (1983) (20)
- Laminar air flow isolation and decontamination: A prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients (1986) (20)
- Comparison of Neutralization and DNA Restriction Enzyme Methods for Typing Clinical Isolates of Human Adenovirus (1985) (18)
- Comparison of MRC-5 and HFF cells for the identification of cytomegalovirus in centrifugation culture. (1987) (18)
- Chemoprophylaxis of viral infection in immunocompromised patients. (1989) (17)
- Multisite evaluation of a monoclonal antibody reagent (Syva) for rapid diagnosis of cytomegalovirus in the shell vial assay (1989) (17)
- Increased cytotoxicity against cytomegalovirus-infected target cells by bronchoalveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia. (1988) (16)
- Long-Term Follow-up of Patients With Invasive Fungal Disease Who Received Adjunctive Therapy With Recombinant Human Macrophage Colony-Stimulating Factor (2003) (16)
- Zoster-immune globulin in high-risk children. (1974) (16)
- Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention. (1984) (15)
- Chronic Graft-versus-Host Disease: Pathogenesis, Diagnosis, Treatment, and Prognostic Factors (1988) (15)
- Prevention and treatment of cytomegalovirus infection after marrow transplantation. (1988) (15)
- Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia (1989) (14)
- Immunologic and clinical responses to varicella-zoster virus-specific transfer factor following marrow transplantation. (1985) (14)
- Nosocomial varicella. Part II: suggested guidelines for management. (1979) (12)
- Detection of human cytomegalovirus in clinical specimens by centrifugation culture with a nonhuman cell line (1992) (11)
- Toxicity trial of prophylactic 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine (ganciclovir) after marrow transplantation in dogs (1988) (11)
- Legionnaires' disease bacterium: prevalence of antibody reacting with the organism in patients suspected of having infection with Pneumocystis carinii. (1980) (11)
- Lack of transmission of hepatitis B after surgical exposure. (1978) (10)
- Comparison of neutralization and DNA restriction enzyme methods for typing clinical isolates of human adenovirus (1985) (9)
- Evaluation of the CMV-CUBE assay for detection of cytomegalovirus serologic status in marrow transplant patients and marrow donors (1990) (8)
- Infectious complications of marrow transplant: risk factors for infection. (1989) (8)
- COMPARISON OF INTERLEUKIN 2 AND GAMMA‐INTERFERON PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS IN RESPONSE TO CYTOMEGALOVIRUS AFTER MARROW TRANSPLANTATION (1990) (8)
- Serologic response to revaccination with two rubella vaccines. (1976) (8)
- Bacterial, Fungal, and Protozoan Infection After Marrow Transplantation (1988) (8)
- Design and Use of Double Lumen Right Atrial Catheters in Bone Marrow Transplant Recipients (1985) (7)
- Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens from marrow transplant patients: evaluation of a direct fluorescein-conjugated monoclonal antibody reagent. (1989) (7)
- Use of serum substitutes for the growth of four cell lines commonly used for virus isolation. (1990) (6)
- Relationship between Antibody to LAV/HTLV‐III and the Natural Course of Subclinical Cellular Immune Dysfunction in Homosexual Men (1987) (6)
- Comparison of MRC-5 and U-373MG astrocytoma cells for detection of cytomegalovirus in shell vial centrifugation cultures (1991) (6)
- Treatment of cytomegalovirus infection. (1987) (5)
- Detection of herpes simplex virus from clinical specimens by centrifugation enhanced cell culture in MRC-5, primary rabbit kidney and mink lung cells (1989) (5)
- Serologic confirmation and typing of clinical herpes simplex virus isolates: comparison of two different monoclonal antibody immunofluorescence kits (1988) (5)
- Supportive care of the marrow transplant recipient: the Seattle Experience. (1990) (5)
- Long-term complications of bone marrow transplantation. (1989) (4)
- Acyclovir for immunocompromised patients with herpes zoster. (1983) (4)
- Critical evaluation of agents used in the treatment and prevention of cytomegalovirus infection in immunocompromised patients. (1991) (3)
- Prevention and treatment of cytomegalovirus infections with interferons and immune globulins (1984) (3)
- after allogeneic marrow transplantation Cytomegalovirus antigen detection in peripheral blood leukocytes (2011) (2)
- Prevention and treatment of cytomegalovirus infections with interferons and immune globulins (1984) (2)
- Immunohistology and In-Situ Hybridization in the Diagnosis of Gastrointestinal Infections (1987) (2)
- Herpes Simplex Virus Pneumonia (2020) (2)
- Fate of right atrial catheters inserted prior to arrival at a transplant center. (1987) (2)
- Treatment of herpesvirus infections in the immunocompromised host. (1985) (2)
- The use of foscarnet for treatment of cytomegalovirus cmv associated marrow suppression ms after marrow transplant (1991) (1)
- Cytotoxic activity against varicella-zoster virus-infected target cells after marrow transplantation. (1990) (1)
- Confirmation of cytomegalovirus isolates using subculture enhancement and immunofluorescent staining with immediate early and early monoclonal antibodies (1987) (1)
- Effect of indomethacin on the in vitro lymphocyte transformation response to herpes simplex virus antigen and phytohemagglutinin after marrow transplant. (1982) (1)
- Marrow Transplantation for Severe Aplastic Anemia (2020) (1)
- Protective Environment for Marrow Transplant Recipients (2020) (1)
- GUIDELINES FOR PREVENTING OPPORTUNISTIC OF CYTOMEGALOVIRUS INFECTION AFTER MARROW TRANSPLANTATION (1988) (0)
- PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS INFECTIONl (1991) (0)
- Determination of patient herpes simplex virus immune status by latex agglutination (1988) (0)
- Alive in continuous remission Alive after relapse Transplant deaths ’ Causes of Death Relapse Graft failure and infection Without GVHD CMV pneumonia Other infection Hemorrhage VOD of liver CMV pneumonia Other infection Pulmonary failure With chronic GVHD Infection CMV pneumonia (2003) (0)
- Prevalence of Antibody Reacting with the Organism in Patients Suspected of Having Infection with Pneumocysfis carin;;1, 2 (1980) (0)
- Immunofluorescent localization of sodium conductance in cultured rat alveolar type ii pneumocytes (1987) (0)
- Frozen section diagnosis of cytomegalovirus infections. (1982) (0)
- Supportive care of the marrow transplant recipient (1990) (0)
- Letters to the Editor Leukocyte Stabilization Reagent for Use in the Cytomegalovirus pp65 Antigenemia Assay (1999) (0)
This paper list is powered by the following services:
